Caris Life Sciences, Inc. (CAI)
19.53
-1.32
(-6.33%)
USD |
NASDAQ |
Feb 20, 16:00
19.52
-0.01
(-0.05%)
After-Hours: 20:00
Caris Life Sciences Total Assets (Quarterly) : 984.57M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Neurocrine Biosciences, Inc. | 4.753B |
| Glaukos Corp. | 893.49M |
| Edgewise Therapeutics, Inc. | 583.47M |
| Nuvalent, Inc. | 979.91M |
| Alphatec Holdings, Inc. | 787.25M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 506.21M |
| Shareholders Equity (Quarterly) | 478.36M |
| Debt to Equity Ratio | 0.8921 |
| Current Ratio | 9.930 |
| Net Debt Paydown Yield | -1.00% |